SEC Proposes Amendments to Exchange Act Rule 15c2-11
Clarification of regulatory scope to limit Rule 15c2-11 application to equity securities only
Advisory Assessment
Impact. This proposed amendment clarifies that Exchange Act Rule 15c2-11 applies exclusively to equity securities, codifying what most broker-dealers already understood to be the rule's scope. The change eliminates regulatory ambiguity around OTC quotation requirements for non-equity instruments without imposing new substantive compliance burdens.
Risk. Legal review processes face the primary exposure here, as firms need to verify their current Rule 15c2-11 interpretations align with the proposed clarification. Trading operations may discover gaps if they've been applying broader interpretations to debt or other non-equity OTC quotations.
Recommended Action. Legal should conduct a focused review of existing Rule 15c2-11 policies and procedures to confirm they reflect equity-only application. Trading operations should audit recent OTC quotation activities to identify any instances where Rule 15c2-11 requirements were applied to non-equity securities.
Watch. The 60-day comment period closes soon, with final implementation expected beyond 180 days. Monitor whether industry comments reveal unexpected interpretive issues that could broaden the rule's final scope or introduce new compliance requirements during the finalization process.
Classification
- Regulatory Program
- Exchange Act Rule 15c2-11
- Doc Type
- Proposed Rule
- Effective Date
- — Date not stated
- Days to Action
- —
- Comment Deadline
- —
- Published
- —
Urgency Basis
Proposed rule with 60-day comment period - likely >180 days to final implementation
Operational Context
Impact by Category
Key Requirements
Scoring Rationale
This is a clarifying amendment with limited operational impact. The proposal narrows Rule 15c2-11's scope to equity securities only, which was already the understood application. Most scores are low (1-2) as this represents regulatory clarification rather than substantive new requirements. Only applies to institutions engaged in OTC market activities.